TGA Approves Record Number Of Medical Cannabis Applications
Up to 31 July 2020, the Australia’s Therapeutic Goods Administration (TGA) had approved more than 56,000 SAS Category B applications for unapproved medicinal cannabis products.
Southern Cannabis Holdings to present at medical cannabis webinar on Tuesday
Southern Cannabis Holdings’ director and chief executive officer Tim Drury is set to present at Proactive’s medical cannabis virtual investor conference on Tuesday, August 11 at 12pm AEST (10am AWST).
Pros and cons to cannabis legislation, Police Association says
Legalising cannabis may put more pressure on police resources and, if the pricing system is not correct, could fail to dent the black market, the Police Association says.
AusCann makes medicinal cannabis sales, briefing doctors
A medicinal cannabis producer with Tasmanian links has supplied its first patients and is briefing doctors on its products.
AusCann Group Holdings Limited – which has an agreement to source cannabis resin from Westbury-based Tasmanian Alkaloids – said the first orders of its controlled-dose capsules were received during the June quarter and supplied to Australian patients under special access schemes.
Friendly Stranger Holdings Corp. on Track to Become Ontario’s Largest Cannabis Retailers
TORONTO, Aug. 10, 2020 /CNW/ – Friendly Stranger Holdings Corp (“FSHC” or the “Company”) today announced it is on track to have 15 licensed cannabis retail stores open by the end of 2020 with five more by April 20, 2021. Stores will open under the Company’s three brands which includes the iconic legacy brands Friendly Stranger, Hotbox Shop (“HotboxTM”) and Happy Dayz. Adding to the three existing Friendly Stranger cannabis retail stores, FSHC will become one of the largest cannabis retailers in Ontario with 17 additional locations planned across the province.
Emerald Clinics signs cannabis RWE contract with Canopy Growth’s UK subsidiary Spectrum Biomedical
Real-world evidence company Emerald Clinics (ASX: EMD) has hauled in a significant new client in the form of Spectrum Biomedical UK (SBUK), the UK-based subsidiary of the world’s largest cannabis company Canopy Growth, to develop a real-world evidence (RWE) system in the UK.
Nong Nooch gets into medical marijuana
Nong Nooch Tropical Garden partnered with the Department of Traditional and Alternative Medicines to showcase medical marijuana’s uses in Thai medicine.
Department Director-General Marut Jirasettasiri and park director Kampol Tansajja signed their partnership agreement and laid the cornerstone of the Cannabis and Hemp Strains Research and Development Center at the Najomtien tourist attraction Aug. 8.
CBD Supply Seen Shrinking as Farmers Flee Hemp: Cannabis Weekly
(Bloomberg) — U.S. farmers appear to be fleeing the hemp market after a rush last year to meet over-hyped CBD demand resulted in plunging prices and warehouses full of unsold supply.
Top Senate Democrat Pushes USDA To Delay Hemp Rules Until 2022
The top Democrat in the Senate is asking the U.S. Department of Agriculture (USDA) to delay issuing final regulations for hemp until 2022, citing stakeholder concerns and the challenges of state compliance that have arisen due to the coronavirus pandemic.
U.S. CBD maker CV Sciences records $4.7 million loss in 2nd quarter
U.S.-based CBD maker CV Sciences said it had operating losses of $4.7 million in the second quarter of 2020, a $6 million swing compared to second quarter profits of $1.3 million in 2019. Revenues fell to $5.4 million in the period, plunging 68% from $16.9 million recorded in the second quarter of last year, the San Diego-based company said in an earnings report. The revenue is also a decrease from the $8.3 million CV Sciences reported in the year’s first quarter ending March 31.